Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07194928 · ClinicalTrials.gov registry record
Medical Cannabis as an Opiate Alternative
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 29
- Enrollment target
NCT07194928: Completed study, sponsored by University of Pennsylvania.
NCT07194928 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07194928 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
Medical Cannabis is very safe and a viable option for pain relief to improve patients and their family's quality of life. However, medical cannabis is not covered by insurance and is an out of pocket expense. This has been a barrier to some patients trying medical cannabis as an alternative. Recruitment and inclusion/exclusion criteria: Potential participants will be recruited from an outpatient chronic pain clinic. 40 patients who have agreed to attempt wean down on opioid medication and have a diagnosis which qualifies them for medical marijuana will be selected for the study. In these selected patients, cost of the treatment was the main barrier for starting medical cannabis. Each participant will undergo a urine drug screen, a pain assessment using the visual analog scale and pain quality will be assessed using the Short Form-36 health related quality, prior to receiving medical cannabis. Each patient will have an individualized plan for weaning off their opioids which is their standard care plan. The patient will go to the select medical cannabis dispensary. The patient will be followed up monthly for five months by physician and will assess the patient's pain levels and Medical Cannabis doses and opioid doses monthly. The investigators will also note the patient side effects, tolerance and any decrease in symptoms. At five months the physician will recheck a urine drug screen, current pain level and readminister the Short form-36 health related quality. The Medical Cannabis doses and strains will be noted.
Primary Outcome
The Numeric Rating Scale is measured from Zero which is equivalent to no pain to 10 which indicates the worst possible pain.
Interventions
- OTHER We will monitor patient's response to medical marijuana as alternative to opioid for chronic pain.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2025-10-01 |
What the finished NCT07194928 record still lists
NCT07194928 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which We will monitor patient's response to medical marijuana as alternative to opioid for chronic pain. is the first listed.
NCT07194928 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07194928 about?
NCT07194928 is a clinical study titled "Medical Cannabis as an Opiate Alternative". Medical Cannabis is very safe and a viable option for pain relief to improve patients and their family's quality of life. However, medical cannabis is not covered by insurance and is an out of pocket expense. This has been a barrier to some patients trying medical cannabis as an alternative. Recrui...
What is the current status of trial NCT07194928?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2024-09-01. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT07194928?
The interventions under investigation include: We will monitor patient's response to medical marijuana as alternative to opioid for chronic pain. (OTHER).
Who is sponsoring clinical trial NCT07194928?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI